BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34603803)

  • 21. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis.
    Schimke LF; Sawalle-Belohradsky J; Roesler J; Wollenberg A; Rack A; Borte M; Rieber N; Cremer R; Maass E; Dopfer R; Reichenbach J; Wahn V; Hoenig M; Jansson AF; Roesen-Wolff A; Schaub B; Seger R; Hill HR; Ochs HD; Torgerson TR; Belohradsky BH; Renner ED
    J Allergy Clin Immunol; 2010 Sep; 126(3):611-7.e1. PubMed ID: 20816194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Child with Elevated IgE and Infection Susceptibility.
    Freeman AF; Milner JD
    Curr Allergy Asthma Rep; 2020 Aug; 20(11):65. PubMed ID: 32830295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retained primary teeth in STAT3 hyper-IgE syndrome: early intervention in childhood is essential.
    Meixner I; Hagl B; Kröner CI; Spielberger BD; Paschos E; Dückers G; Niehues T; Hesse R; Renner ED
    Orphanet J Rare Dis; 2020 Sep; 15(1):244. PubMed ID: 32912316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
    van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
    Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole Genome Sequencing Reveals a Chromosome 9p Deletion Causing DOCK8 Deficiency in an Adult Diagnosed with Hyper IgE Syndrome Who Developed Progressive Multifocal Leukoencephalopathy.
    Day-Williams AG; Sun C; Jelcic I; McLaughlin H; Harris T; Martin R; Carulli JP
    J Clin Immunol; 2015 Jan; 35(1):92-6. PubMed ID: 25388448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary Immunodeficiencies with Elevated IgE.
    Mogensen TH
    Int Rev Immunol; 2016; 35(1):39-56. PubMed ID: 25970001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case Report: DOCK8 Deficiency Without Hyper-IgE in a Child With a Large Deletion.
    Venegas-Montoya E; Staines-Boone AT; Sánchez-Sánchez LM; García-Campos JA; Córdova-Gurrola RA; Salazar-Galvez Y; Múzquiz-Zermeño D; González-Serrano ME; Lugo Reyes SO
    Front Pediatr; 2021; 9():635322. PubMed ID: 34195158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hyper-IgE syndromes].
    He YY; Liu B; Xiao XP
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):892-896. PubMed ID: 29775011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypomorphic function and somatic reversion of DOCK8 cause combined immunodeficiency without hyper-IgE.
    Kienzler AK; van Schouwenburg PA; Taylor J; Marwah I; Sharma RU; Noakes C; Thomson K; Sadler R; Segal S; Ferry B; Taylor JC; Blair E; Chapel H; Patel SY
    Clin Immunol; 2016 Feb; 163():17-21. PubMed ID: 26680607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease.
    Dorjbal B; Stinson JR; Ma CA; Weinreich MA; Miraghazadeh B; Hartberger JM; Frey-Jakobs S; Weidinger S; Moebus L; Franke A; Schäffer AA; Bulashevska A; Fuchs S; Ehl S; Limaye S; Arkwright PD; Briggs TA; Langley C; Bethune C; Whyte AF; Alachkar H; Nejentsev S; DiMaggio T; Nelson CG; Stone KD; Nason M; Brittain EH; Oler AJ; Veltri DP; Leahy TR; Conlon N; Poli MC; Borzutzky A; Cohen JI; Davis J; Lambert MP; Romberg N; Sullivan KE; Paris K; Freeman AF; Lucas L; Chandrakasan S; Savic S; Hambleton S; Patel SY; Jordan MB; Theos A; Lebensburger J; Atkinson TP; Torgerson TR; Chinn IK; Milner JD; Grimbacher B; Cook MC; Snow AL
    J Allergy Clin Immunol; 2019 Apr; 143(4):1482-1495. PubMed ID: 30170123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated IgE Levels-An Allergy or an Underlying Inborn Error of Immunity in Children with Recurrent Infections?
    Kostova P; Papochieva V; Miteva D; Georgieva B; Mileva S; Shahid M; Lukanov T; Petrova G
    Antibodies (Basel); 2023 Nov; 12(4):. PubMed ID: 37987248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine imbalance in hyper-IgE syndrome: reduced expression of transforming growth factor beta and interferon gamma genes in circulating activated T cells.
    Ohga S; Nomura A; Ihara K; Takahata Y; Suga N; Akeda H; Shibata R; Okamura J; Kinukawa N; Hara T
    Br J Haematol; 2003 Apr; 121(2):324-31. PubMed ID: 12694256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atopic dermatitis or hyper-IgE syndrome?
    Ohameje NU; Loveless JW; Saini SS
    Allergy Asthma Proc; 2006; 27(3):289-91. PubMed ID: 16913276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotyping and long-term follow up of patients with hyper IgE syndrome.
    Alyasin S; Esmaeilzadeh H; Ebrahimi N; Nabavizadeh SH; Kashef S; Esmaeilzadeh E; Babaei M; Amin R
    Allergol Immunopathol (Madr); 2019; 47(2):152-158. PubMed ID: 30279075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel PGM3 compound heterozygous variants with IgE-related dermatitis, lymphopenia, without syndromic features.
    García-García A; Buendia Arellano M; Deyà-Martínez À; Lozano Blasco J; Serrano M; Van Den Rym A; García-Solis B; Esteve-Solé A; Yiyi L; Vlagea A; Solanich X; Fisher MR; Lyons JJ; de Diego RP; Alsina L
    Pediatr Allergy Immunol; 2021 Apr; 32(3):566-575. PubMed ID: 33098103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyper-IgE syndrome with a novel STAT3 mutation-a single center study from India.
    Saikia B; Suri D; Goel S; Rawat A; Minz RW; Gupta A; Sharma S; Ohara O; Imai K; Nonoyama S; Sehgal S; Singh S
    Asian Pac J Allergy Immunol; 2014 Dec; 32(4):321-7. PubMed ID: 25543043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes T
    Keles S; Charbonnier LM; Kabaleeswaran V; Reisli I; Genel F; Gulez N; Al-Herz W; Ramesh N; Perez-Atayde A; Karaca NE; Kutukculer N; Wu H; Geha RS; Chatila TA
    J Allergy Clin Immunol; 2016 Nov; 138(5):1384-1394.e2. PubMed ID: 27350570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome.
    Alonso-Bello CD; Jiménez-Martínez MDC; Vargas-Camaño ME; Hierro-Orozco S; Ynga-Durand MA; Berrón-Ruiz L; Alcántara-Montiel JC; Santos-Argumedo L; Herrera-Sánchez DA; Lozano-Patiño F; Castrejón-Vázquez MI
    Case Reports Immunol; 2019; 2019():6357256. PubMed ID: 31355024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation.
    Al Shekaili L; Sheikh F; Al Gazlan S; Al Dhekri H; Al Mousa H; Al Ghonaium A; Al Saud B; Al Mohsen S; Rehan Khaliq AM; Al Sumayli S; Al Zahrani M; Dababo A; AlKawi A; Hawwari A; Arnaout R
    Clin Immunol; 2017 May; 178():39-44. PubMed ID: 27890707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Severe atopy and allergy--rare hyper-IgE syndrome caused by the DOCK8 mutation as underlying condition].
    Koskenvuo M; Kainulainen L; Vanto T; Lukkarinen H; Lähteenmäki P; Ruuskanen O
    Duodecim; 2015; 131(6):541-4. PubMed ID: 26237897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.